Gillson Capital LP trimmed its stake in CME Group Inc (NASDAQ:CME) by 1.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 46,991 shares of the financial services provider’s stock after selling 691 shares during the quarter. Gillson Capital LP’s holdings in CME Group were worth $6,863,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also made changes to their positions in the stock. ARK Investment Management LLC bought a new position in shares of CME Group in the 4th quarter worth $120,000. Valeo Financial Advisors LLC bought a new position in shares of CME Group in the 3rd quarter worth $124,000. AlphaOne Investment Services LLC bought a new position in shares of CME Group during the 4th quarter valued at $146,000. Mosaic Family Wealth LLC bought a new position in shares of CME Group during the 4th quarter valued at $146,000. Finally, Truewealth LLC bought a new position in shares of CME Group during the 4th quarter valued at $157,000. Institutional investors own 83.13% of the company’s stock.
In other news, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total transaction of $31,982.00. Following the transaction, the director now owns 3,809 shares in the company, valued at $609,097.19. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,299 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 43,024 shares of company stock worth $6,620,113. Company insiders own 0.57% of the company’s stock.
Shares of CME Group Inc (NASDAQ CME) traded down $1.86 on Wednesday, reaching $162.95. 2,248,928 shares of the company traded hands, compared to its average volume of 1,663,015. CME Group Inc has a 12 month low of $114.82 and a 12 month high of $171.71. The company has a market capitalization of $57,586.33, a PE ratio of 13.81, a PEG ratio of 2.49 and a beta of 0.54. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.03.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter in the previous year, the business posted $1.14 earnings per share. The business’s revenue was down 1.4% compared to the same quarter last year. analysts anticipate that CME Group Inc will post 6.47 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be issued a $0.70 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This is a boost from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.72%. CME Group’s dividend payout ratio is presently 23.45%.
CME has been the topic of several recent research reports. Goldman Sachs Group raised shares of CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a report on Wednesday, February 7th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research report on Tuesday, January 2nd. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Citigroup reissued a “buy” rating and set a $172.00 price target (up from $155.00) on shares of CME Group in a research report on Monday, January 29th. Finally, Bank of America lifted their price target on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Five equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $157.77.
ILLEGAL ACTIVITY WARNING: “Gillson Capital LP Has $6.86 Million Stake in CME Group Inc (CME)” was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.thelincolnianonline.com/2018/03/14/gillson-capital-lp-sells-691-shares-of-cme-group-inc-cme.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.